Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia.

Jeyaraman, Preethi; Naithani, Rahul

Jeyaraman, Preethi; Naithani, Rahul.

Affiliation

Jeyaraman P; Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, New Delhi, India.

J Pediatr Hematol Oncol ; 42(1): e64-e65, 2020 01.

Article in En | MEDLINE | ID: mdl-31688623

Subject(s)

Imatinib Mesylate/administration & dosage; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Adolescent; Follow-Up Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imatinib Mesylate Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Humans / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2020 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google